BioScrip Inc. (Nasdaq: BIOS) expects fourth quarter results to be at the high end of its guidance and announced a proposed Amendment to its Credit Agreement. The stock price soared 36 cents to close at $1.40.
BioScrip amends credit agreement
January 03, 2017 at 17:09 PM EST